9 Meters Biopharma (NMTR) Reports Q4 Results, Provides Business Update
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. 9 Meters Biopharma, Inc. (NASDAQ: NMTR), a clinical-stage company pioneering novel treatments for people with rare or…